qPCRおよびdPCR装置の世界市場

qPCRおよびdPCR装置の世界市場は2030年までに135億米ドルに達する

COVID-19後のビジネス環境が変化する中、2022年に71億米ドルと推定されたqPCRおよびdPCR装置の世界市場は、2030年には135億米ドルに達すると予測され、2022年から2030年にかけてCAGR8.5%で成長すると予測されます。本レポートで分析したセグメントの一つであるqPCRは、CAGR8%を記録し、分析期間終了時には113億米ドルに達すると予測されます。現在進行中のパンデミック後の回復を考慮し、dPCR分野の成長は今後8年間のCAGR 11.4%に再調整されます。

米国市場は22億米ドル、中国はCAGR 11.2%で成長予測

米国のqPCRおよびdPCR装置市場は、2022年には22億米ドルになると推定されます。世界第2位の経済大国である中国は、2022年から2030年のCAGR11.2%で、2030年までに12億米ドルの市場規模に達すると予測されています。その他の注目すべき地理的市場としては、日本とカナダがあり、2022年から2030年にかけてそれぞれ7%と7.2%の成長が予測されています。欧州では、ドイツがCAGR約7.7%で成長すると予測されています。

調査対象企業の例

• Abbott Laboratories, Inc.
• Agilent Technologies, Inc.
• Becton, Dickinson and Company
• Beckman Coulter, Inc.
• Bio-Rad Laboratories, Inc.
• bioMerieux SA
• Asuragen, Inc.
• Analytik Jena AG
• Biocartis NV
• Biotecon Diagnostics GmbH
• BioFire Diagnostics LLC
• Alifax SpA
• Anitoa Systems LLC
• AB ANALITICA s.r.l.
• Bio Molecular Systems

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

What`s New for 2023?

»Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.

»Global competitiveness and key competitor percentage market shares

» Market presence across multiple geographies - Strong/Active/Niche/Trivial

»Online interactive peer-to-peer collaborative bespoke updates

»Access to our digital archives and MarketGlass Research Platform

»Complimentary updates for one year

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global qPCR and dPCR Instrumentation Market to Reach $13.5 Billion by 2030

In the changed post COVID-19 business landscape, the global market for qPCR and dPCR Instrumentation estimated at US$7.1 Billion in the year 2022, is projected to reach a revised size of US$13.5 Billion by 2030, growing at aCAGR of 8.5% over the period 2022-2030. qPCR, one of the segments analyzed in the report, is projected to record 8% CAGR and reach US$11.3 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the dPCR segment is readjusted to a revised 11.4% CAGR for the next 8-year period.

The U.S. Market is Estimated at $2.2 Billion, While China is Forecast to Grow at 11.2% CAGR

The qPCR and dPCR Instrumentation market in the U.S. is estimated at US$2.2 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.2 Billion by the year 2030 trailing a CAGR of 11.2% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 7% and 7.2% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 7.7% CAGR.

Select Competitors (Total 74 Featured) -

• Abbott Laboratories, Inc.
• Agilent Technologies, Inc.
• Becton, Dickinson and Company
• Beckman Coulter, Inc.
• Bio-Rad Laboratories, Inc.
• bioMerieux SA
• Asuragen, Inc.
• Analytik Jena AG
• Biocartis NV
• Biotecon Diagnostics GmbH
• BioFire Diagnostics LLC
• Alifax SpA
• Anitoa Systems LLC
• AB ANALITICA s.r.l.
• Bio Molecular Systems

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Polymerase Chain Reaction (PCR): An Integral Part of Gene Amplification & Quantification
  • Impact of Covid-19 and a Looming Global Recession
  • 2020 Marked as a Year of Disruption & Transformation
  • World Economic Growth Projections (Real GDP, Annual % Change) for 2019 to 2022
  • Impact of COVID-19 on Clinical Diagnostics
  • Emergence of PCR as a Preferred COVID-19 Detection Method
  • Performance Analysis of COVID-19 Tests
  • Total Number of COVID-19 Tests Conducted in the Most Impacted Countries: As of January 13th, 2021
  • Molecular Tests (RT-PCR) Occupy a Predominant Share of the COVID-19 Testing Market
  • Global COVID-19 Testing Market Breakdown by Testing Type: 2020 and 2027
  • Select Approved Covid-19 Molecular Assay Tests
  • Recent PCR Based Tests
  • Digital PCR Sparks Increasing Interest
  • High-Speed NanoPCR Technology Developed for Point-of-Care Diagnosis of COVID-19
  • CRISPR Emerges as Cutting-Edge Biotechnology in COVID-19 Diagnostic Market
  • Demand for PCR Testing to Remain Buoyant in 2021
  • qPCR and dPCR Instrumentation - Global Key Competitors Percentage Market Share in 2022 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
  • Real-Time PCR and Digital PCR: Scope and Definition
  • Real-Time PCR or Quantitative PCR (qPCR)
  • qPCR Instrumentation
  • Disadvantages
  • Advantages of qPCR
  • End-Use Applications of qPCR
  • Digital PCR (dPCR)
  • Working Principle
  • Applications of dPCR
  • Advantages of dPCR
  • qPCR Remains the Mainstay Technology
  • Digital PCR to Experience Strong Growth
  • High Installation Cost Remains a Roadblock to Widespread Adoption of dPCR
  • Developing Countries Drive Growth Opportunities
  • Competition
  • Competitive Factors
  • Accelerated Commercialization of Products
  • Manufacturers Step-Up Online Exposure
  • Targeted Expansion of Distribution Reach and Global Footprint
  • Recent Market Activity
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Striking the Right Balance between qPCR and dPCR in Research Laboratories
  • qPCR: A Suitable Tool for Gene Expression and Validation
  • Digital PCR Takes Quantification of Nucleic Acids to the Next Level
  • dPCR: A Valuable Tool in Virology Research
  • Increasing Incidence and Prevalence of Cancer: A Grim Reality Driving Demand for qPCR and dPCR
  • Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
  • Breakdown of Total Number of Cancer Cases by Region: 2020
  • Breakdown of Total Number of Cancer Cases by Type: 2020
  • dPCR for Analyzing Hematologic Malignancies
  • dPCR for Liquid Biopsies
  • Progress in Molecular Diagnostics Spur Demand for the Gene Amplification Technologies
  • Prospects for Predictive Genetic Diagnostics and Testing Grow Brighter
  • Global Prenatal Diagnostics Market in US$ Billion: 2015 and 2022
  • Global Genetic Testing Market in US$ Billion: 2020 and 2027
  • Rise in Infectious Diseases Drives Opportunities for Biochips
  • Infectious Diseases Remain Major Cause of Death in Under Developed Regions: Breakdown of Leading Causes of Death in Sub-Saharan Africa (in %)
  • Infectious Diseases Related Mortality High Among Children Below 5 Years: Breakdown of Leading Causes of Death in Children Below 5 Years (in %)
  • Innovations in Instrumentation Expand Functionality and Drive Adoption
  • Advancements in Probe Technology Enhance qPCR Sensitivity
  • qPCR Market to Witness Increasing Affinity for Automated and Robotic Equipment
  • Lab on Chip/Microfluidic Real-time-PCR
  • Synoptic Review of Quantitative PCR Technical Advancements in the Recent Years
  • ddPCR: The More Advanced Digital Approach to dPCR
  • ddPCR Gains Traction in Cancer Diagnosis
  • Monitoring Disease Progression in HIV Studies
  • Global HIV Prevalence: Number of People Living with AIDs (in Thousands) by Region for 2018
  • Analysis of Genetically Modified Organisms in Edible Products
  • RT-ddPCR Techniques Applied for Quantitating RNA Viruses in Water Samples
  • Technology Advancements Aid in Overcoming Barriers
  • Alternate Technologies Pose Threat to Growth of PCR Market
  • Next-Generation Sequencing to Emerge as Novel Technique in Fight with COVID-19
  • Improving Healthcare Expenditure to Drive Demand for qPCR and dPCR-based Tests
  • World Healthcare Expenditure (In US$ Billion) for the Years 2017-2023
  • PCR in Forensic and Paternity Testing
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Recent Past, Current & Future Analysis for qPCR by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2022 through 2030 and % CAGR
  • TABLE 2: World Historic Review for qPCR by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 3: World 16-Year Perspective for qPCR by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • TABLE 4: World Recent Past, Current & Future Analysis for dPCR by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2022 through 2030 and % CAGR
  • TABLE 5: World Historic Review for dPCR by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 6: World 16-Year Perspective for dPCR by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • TABLE 7: World Recent Past, Current & Future Analysis for Reagents & Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2022 through 2030 and % CAGR
  • TABLE 8: World Historic Review for Reagents & Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 9: World 16-Year Perspective for Reagents & Consumables by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • TABLE 10: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2022 through 2030 and % CAGR
  • TABLE 11: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 12: World 16-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • TABLE 13: World Recent Past, Current & Future Analysis for Software & Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2022 through 2030 and % CAGR
  • TABLE 14: World Historic Review for Software & Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 15: World 16-Year Perspective for Software & Services by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • TABLE 16: World Recent Past, Current & Future Analysis for Hospitals & Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2022 through 2030 and % CAGR
  • TABLE 17: World Historic Review for Hospitals & Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 18: World 16-Year Perspective for Hospitals & Diagnostic Centers by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • TABLE 19: World Recent Past, Current & Future Analysis for Research Laboratories & Academic Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2022 through 2030 and % CAGR
  • TABLE 20: World Historic Review for Research Laboratories & Academic Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 21: World 16-Year Perspective for Research Laboratories & Academic Institutes by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • TABLE 22: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2022 through 2030 and % CAGR
  • TABLE 23: World Historic Review for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 24: World 16-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • TABLE 25: World Recent Past, Current & Future Analysis for Clinical Research Organizations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2022 through 2030 and % CAGR
  • TABLE 26: World Historic Review for Clinical Research Organizations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 27: World 16-Year Perspective for Clinical Research Organizations by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • TABLE 28: World Recent Past, Current & Future Analysis for Forensic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2022 through 2030 and % CAGR
  • TABLE 29: World Historic Review for Forensic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 30: World 16-Year Perspective for Forensic Laboratories by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • TABLE 31: World qPCR and dPCR Instrumentation Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2022 through 2030 and % CAGR
  • TABLE 33: World Historic Review for qPCR and dPCR Instrumentation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 34: World 16-Year Perspective for qPCR and dPCR Instrumentation by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2023 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • qPCR and dPCR Instrumentation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
  • TABLE 35: USA Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 36: USA Historic Review for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 37: USA 16-Year Perspective for qPCR and dPCR Instrumentation by Classification - Percentage Breakdown of Value Revenues for qPCR and dPCR for the Years 2014, 2023 & 2030
  • TABLE 38: USA Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 39: USA Historic Review for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 40: USA 16-Year Perspective for qPCR and dPCR Instrumentation by Component - Percentage Breakdown of Value Revenues for Reagents & Consumables, Instruments and Software & Services for the Years 2014, 2023 & 2030
  • TABLE 41: USA Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 42: USA Historic Review for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 43: USA 16-Year Perspective for qPCR and dPCR Instrumentation by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories for the Years 2014, 2023 & 2030
• CANADA
  • TABLE 44: Canada Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 45: Canada Historic Review for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 46: Canada 16-Year Perspective for qPCR and dPCR Instrumentation by Classification - Percentage Breakdown of Value Revenues for qPCR and dPCR for the Years 2014, 2023 & 2030
  • TABLE 47: Canada Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 48: Canada Historic Review for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 49: Canada 16-Year Perspective for qPCR and dPCR Instrumentation by Component - Percentage Breakdown of Value Revenues for Reagents & Consumables, Instruments and Software & Services for the Years 2014, 2023 & 2030
  • TABLE 50: Canada Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 51: Canada Historic Review for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 52: Canada 16-Year Perspective for qPCR and dPCR Instrumentation by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories for the Years 2014, 2023 & 2030
• JAPAN
  • qPCR and dPCR Instrumentation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
  • TABLE 53: Japan Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 54: Japan Historic Review for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 55: Japan 16-Year Perspective for qPCR and dPCR Instrumentation by Classification - Percentage Breakdown of Value Revenues for qPCR and dPCR for the Years 2014, 2023 & 2030
  • TABLE 56: Japan Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 57: Japan Historic Review for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 58: Japan 16-Year Perspective for qPCR and dPCR Instrumentation by Component - Percentage Breakdown of Value Revenues for Reagents & Consumables, Instruments and Software & Services for the Years 2014, 2023 & 2030
  • TABLE 59: Japan Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 60: Japan Historic Review for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 61: Japan 16-Year Perspective for qPCR and dPCR Instrumentation by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories for the Years 2014, 2023 & 2030
• CHINA
  • qPCR and dPCR Instrumentation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
  • TABLE 62: China Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 63: China Historic Review for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 64: China 16-Year Perspective for qPCR and dPCR Instrumentation by Classification - Percentage Breakdown of Value Revenues for qPCR and dPCR for the Years 2014, 2023 & 2030
  • TABLE 65: China Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 66: China Historic Review for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 67: China 16-Year Perspective for qPCR and dPCR Instrumentation by Component - Percentage Breakdown of Value Revenues for Reagents & Consumables, Instruments and Software & Services for the Years 2014, 2023 & 2030
  • TABLE 68: China Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 69: China Historic Review for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 70: China 16-Year Perspective for qPCR and dPCR Instrumentation by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories for the Years 2014, 2023 & 2030
• EUROPE
  • qPCR and dPCR Instrumentation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
  • TABLE 71: Europe Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 72: Europe Historic Review for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 73: Europe 16-Year Perspective for qPCR and dPCR Instrumentation by Classification - Percentage Breakdown of Value Revenues for qPCR and dPCR for the Years 2014, 2023 & 2030
  • TABLE 74: Europe Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 75: Europe Historic Review for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 76: Europe 16-Year Perspective for qPCR and dPCR Instrumentation by Component - Percentage Breakdown of Value Revenues for Reagents & Consumables, Instruments and Software & Services for the Years 2014, 2023 & 2030
  • TABLE 77: Europe Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 78: Europe Historic Review for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 79: Europe 16-Year Perspective for qPCR and dPCR Instrumentation by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories for the Years 2014, 2023 & 2030
  • TABLE 80: Europe Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2022 through 2030 and % CAGR
  • TABLE 81: Europe Historic Review for qPCR and dPCR Instrumentation by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 82: Europe 16-Year Perspective for qPCR and dPCR Instrumentation by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2023 & 2030
• FRANCE
  • qPCR and dPCR Instrumentation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
  • TABLE 83: France Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 84: France Historic Review for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 85: France 16-Year Perspective for qPCR and dPCR Instrumentation by Classification - Percentage Breakdown of Value Revenues for qPCR and dPCR for the Years 2014, 2023 & 2030
  • TABLE 86: France Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 87: France Historic Review for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 88: France 16-Year Perspective for qPCR and dPCR Instrumentation by Component - Percentage Breakdown of Value Revenues for Reagents & Consumables, Instruments and Software & Services for the Years 2014, 2023 & 2030
  • TABLE 89: France Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 90: France Historic Review for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 91: France 16-Year Perspective for qPCR and dPCR Instrumentation by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories for the Years 2014, 2023 & 2030
• GERMANY
  • qPCR and dPCR Instrumentation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
  • TABLE 92: Germany Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 93: Germany Historic Review for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 94: Germany 16-Year Perspective for qPCR and dPCR Instrumentation by Classification - Percentage Breakdown of Value Revenues for qPCR and dPCR for the Years 2014, 2023 & 2030
  • TABLE 95: Germany Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 96: Germany Historic Review for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 97: Germany 16-Year Perspective for qPCR and dPCR Instrumentation by Component - Percentage Breakdown of Value Revenues for Reagents & Consumables, Instruments and Software & Services for the Years 2014, 2023 & 2030
  • TABLE 98: Germany Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 99: Germany Historic Review for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 100: Germany 16-Year Perspective for qPCR and dPCR Instrumentation by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories for the Years 2014, 2023 & 2030
• ITALY
  • TABLE 101: Italy Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 102: Italy Historic Review for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 103: Italy 16-Year Perspective for qPCR and dPCR Instrumentation by Classification - Percentage Breakdown of Value Revenues for qPCR and dPCR for the Years 2014, 2023 & 2030
  • TABLE 104: Italy Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 105: Italy Historic Review for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 106: Italy 16-Year Perspective for qPCR and dPCR Instrumentation by Component - Percentage Breakdown of Value Revenues for Reagents & Consumables, Instruments and Software & Services for the Years 2014, 2023 & 2030
  • TABLE 107: Italy Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 108: Italy Historic Review for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 109: Italy 16-Year Perspective for qPCR and dPCR Instrumentation by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories for the Years 2014, 2023 & 2030
• UNITED KINGDOM
  • qPCR and dPCR Instrumentation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
  • TABLE 110: UK Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 111: UK Historic Review for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 112: UK 16-Year Perspective for qPCR and dPCR Instrumentation by Classification - Percentage Breakdown of Value Revenues for qPCR and dPCR for the Years 2014, 2023 & 2030
  • TABLE 113: UK Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 114: UK Historic Review for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 115: UK 16-Year Perspective for qPCR and dPCR Instrumentation by Component - Percentage Breakdown of Value Revenues for Reagents & Consumables, Instruments and Software & Services for the Years 2014, 2023 & 2030
  • TABLE 116: UK Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 117: UK Historic Review for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 118: UK 16-Year Perspective for qPCR and dPCR Instrumentation by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories for the Years 2014, 2023 & 2030
• SPAIN
  • TABLE 119: Spain Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 120: Spain Historic Review for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 121: Spain 16-Year Perspective for qPCR and dPCR Instrumentation by Classification - Percentage Breakdown of Value Revenues for qPCR and dPCR for the Years 2014, 2023 & 2030
  • TABLE 122: Spain Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 123: Spain Historic Review for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 124: Spain 16-Year Perspective for qPCR and dPCR Instrumentation by Component - Percentage Breakdown of Value Revenues for Reagents & Consumables, Instruments and Software & Services for the Years 2014, 2023 & 2030
  • TABLE 125: Spain Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 126: Spain Historic Review for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 127: Spain 16-Year Perspective for qPCR and dPCR Instrumentation by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories for the Years 2014, 2023 & 2030
• RUSSIA
  • TABLE 128: Russia Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 129: Russia Historic Review for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 130: Russia 16-Year Perspective for qPCR and dPCR Instrumentation by Classification - Percentage Breakdown of Value Revenues for qPCR and dPCR for the Years 2014, 2023 & 2030
  • TABLE 131: Russia Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 132: Russia Historic Review for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 133: Russia 16-Year Perspective for qPCR and dPCR Instrumentation by Component - Percentage Breakdown of Value Revenues for Reagents & Consumables, Instruments and Software & Services for the Years 2014, 2023 & 2030
  • TABLE 134: Russia Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 135: Russia Historic Review for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 136: Russia 16-Year Perspective for qPCR and dPCR Instrumentation by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories for the Years 2014, 2023 & 2030
• REST OF EUROPE
  • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 138: Rest of Europe Historic Review for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 139: Rest of Europe 16-Year Perspective for qPCR and dPCR Instrumentation by Classification - Percentage Breakdown of Value Revenues for qPCR and dPCR for the Years 2014, 2023 & 2030
  • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 141: Rest of Europe Historic Review for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 142: Rest of Europe 16-Year Perspective for qPCR and dPCR Instrumentation by Component - Percentage Breakdown of Value Revenues for Reagents & Consumables, Instruments and Software & Services for the Years 2014, 2023 & 2030
  • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 144: Rest of Europe Historic Review for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 145: Rest of Europe 16-Year Perspective for qPCR and dPCR Instrumentation by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories for the Years 2014, 2023 & 2030
• ASIA-PACIFIC
  • qPCR and dPCR Instrumentation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
  • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 147: Asia-Pacific Historic Review for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 148: Asia-Pacific 16-Year Perspective for qPCR and dPCR Instrumentation by Classification - Percentage Breakdown of Value Revenues for qPCR and dPCR for the Years 2014, 2023 & 2030
  • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 150: Asia-Pacific Historic Review for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 151: Asia-Pacific 16-Year Perspective for qPCR and dPCR Instrumentation by Component - Percentage Breakdown of Value Revenues for Reagents & Consumables, Instruments and Software & Services for the Years 2014, 2023 & 2030
  • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 153: Asia-Pacific Historic Review for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 154: Asia-Pacific 16-Year Perspective for qPCR and dPCR Instrumentation by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories for the Years 2014, 2023 & 2030
  • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2022 through 2030 and % CAGR
  • TABLE 156: Asia-Pacific Historic Review for qPCR and dPCR Instrumentation by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 157: Asia-Pacific 16-Year Perspective for qPCR and dPCR Instrumentation by Geographic Region - Percentage Breakdown of Value Revenues for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2023 & 2030
• AUSTRALIA
  • qPCR and dPCR Instrumentation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2023 (E)
  • TABLE 158: Australia Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 159: Australia Historic Review for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 160: Australia 16-Year Perspective for qPCR and dPCR Instrumentation by Classification - Percentage Breakdown of Value Revenues for qPCR and dPCR for the Years 2014, 2023 & 2030
  • TABLE 161: Australia Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 162: Australia Historic Review for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 163: Australia 16-Year Perspective for qPCR and dPCR Instrumentation by Component - Percentage Breakdown of Value Revenues for Reagents & Consumables, Instruments and Software & Services for the Years 2014, 2023 & 2030
  • TABLE 164: Australia Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 165: Australia Historic Review for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 166: Australia 16-Year Perspective for qPCR and dPCR Instrumentation by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories for the Years 2014, 2023 & 2030
• INDIA
  • qPCR and dPCR Instrumentation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2023 (E)
  • TABLE 167: India Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 168: India Historic Review for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 169: India 16-Year Perspective for qPCR and dPCR Instrumentation by Classification - Percentage Breakdown of Value Revenues for qPCR and dPCR for the Years 2014, 2023 & 2030
  • TABLE 170: India Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 171: India Historic Review for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 172: India 16-Year Perspective for qPCR and dPCR Instrumentation by Component - Percentage Breakdown of Value Revenues for Reagents & Consumables, Instruments and Software & Services for the Years 2014, 2023 & 2030
  • TABLE 173: India Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 174: India Historic Review for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 175: India 16-Year Perspective for qPCR and dPCR Instrumentation by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories for the Years 2014, 2023 & 2030
• SOUTH KOREA
  • TABLE 176: South Korea Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 177: South Korea Historic Review for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 178: South Korea 16-Year Perspective for qPCR and dPCR Instrumentation by Classification - Percentage Breakdown of Value Revenues for qPCR and dPCR for the Years 2014, 2023 & 2030
  • TABLE 179: South Korea Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 180: South Korea Historic Review for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 181: South Korea 16-Year Perspective for qPCR and dPCR Instrumentation by Component - Percentage Breakdown of Value Revenues for Reagents & Consumables, Instruments and Software & Services for the Years 2014, 2023 & 2030
  • TABLE 182: South Korea Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 183: South Korea Historic Review for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 184: South Korea 16-Year Perspective for qPCR and dPCR Instrumentation by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories for the Years 2014, 2023 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 186: Rest of Asia-Pacific Historic Review for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 187: Rest of Asia-Pacific 16-Year Perspective for qPCR and dPCR Instrumentation by Classification - Percentage Breakdown of Value Revenues for qPCR and dPCR for the Years 2014, 2023 & 2030
  • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 189: Rest of Asia-Pacific Historic Review for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 190: Rest of Asia-Pacific 16-Year Perspective for qPCR and dPCR Instrumentation by Component - Percentage Breakdown of Value Revenues for Reagents & Consumables, Instruments and Software & Services for the Years 2014, 2023 & 2030
  • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 192: Rest of Asia-Pacific Historic Review for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 193: Rest of Asia-Pacific 16-Year Perspective for qPCR and dPCR Instrumentation by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories for the Years 2014, 2023 & 2030
• LATIN AMERICA
  • qPCR and dPCR Instrumentation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2023 (E)
  • TABLE 194: Latin America Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 195: Latin America Historic Review for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 196: Latin America 16-Year Perspective for qPCR and dPCR Instrumentation by Classification - Percentage Breakdown of Value Revenues for qPCR and dPCR for the Years 2014, 2023 & 2030
  • TABLE 197: Latin America Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 198: Latin America Historic Review for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 199: Latin America 16-Year Perspective for qPCR and dPCR Instrumentation by Component - Percentage Breakdown of Value Revenues for Reagents & Consumables, Instruments and Software & Services for the Years 2014, 2023 & 2030
  • TABLE 200: Latin America Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 201: Latin America Historic Review for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 202: Latin America 16-Year Perspective for qPCR and dPCR Instrumentation by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories for the Years 2014, 2023 & 2030
  • TABLE 203: Latin America Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2022 through 2030 and % CAGR
  • TABLE 204: Latin America Historic Review for qPCR and dPCR Instrumentation by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 205: Latin America 16-Year Perspective for qPCR and dPCR Instrumentation by Geographic Region - Percentage Breakdown of Value Revenues for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2023 & 2030
• ARGENTINA
  • TABLE 206: Argentina Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 207: Argentina Historic Review for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 208: Argentina 16-Year Perspective for qPCR and dPCR Instrumentation by Classification - Percentage Breakdown of Value Revenues for qPCR and dPCR for the Years 2014, 2023 & 2030
  • TABLE 209: Argentina Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 210: Argentina Historic Review for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 211: Argentina 16-Year Perspective for qPCR and dPCR Instrumentation by Component - Percentage Breakdown of Value Revenues for Reagents & Consumables, Instruments and Software & Services for the Years 2014, 2023 & 2030
  • TABLE 212: Argentina Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 213: Argentina Historic Review for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 214: Argentina 16-Year Perspective for qPCR and dPCR Instrumentation by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories for the Years 2014, 2023 & 2030
• BRAZIL
  • TABLE 215: Brazil Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 216: Brazil Historic Review for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 217: Brazil 16-Year Perspective for qPCR and dPCR Instrumentation by Classification - Percentage Breakdown of Value Revenues for qPCR and dPCR for the Years 2014, 2023 & 2030
  • TABLE 218: Brazil Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 219: Brazil Historic Review for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 220: Brazil 16-Year Perspective for qPCR and dPCR Instrumentation by Component - Percentage Breakdown of Value Revenues for Reagents & Consumables, Instruments and Software & Services for the Years 2014, 2023 & 2030
  • TABLE 221: Brazil Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 222: Brazil Historic Review for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 223: Brazil 16-Year Perspective for qPCR and dPCR Instrumentation by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories for the Years 2014, 2023 & 2030
• MEXICO
  • TABLE 224: Mexico Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 225: Mexico Historic Review for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 226: Mexico 16-Year Perspective for qPCR and dPCR Instrumentation by Classification - Percentage Breakdown of Value Revenues for qPCR and dPCR for the Years 2014, 2023 & 2030
  • TABLE 227: Mexico Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 228: Mexico Historic Review for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 229: Mexico 16-Year Perspective for qPCR and dPCR Instrumentation by Component - Percentage Breakdown of Value Revenues for Reagents & Consumables, Instruments and Software & Services for the Years 2014, 2023 & 2030
  • TABLE 230: Mexico Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 231: Mexico Historic Review for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 232: Mexico 16-Year Perspective for qPCR and dPCR Instrumentation by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories for the Years 2014, 2023 & 2030
• REST OF LATIN AMERICA
  • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 234: Rest of Latin America Historic Review for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 235: Rest of Latin America 16-Year Perspective for qPCR and dPCR Instrumentation by Classification - Percentage Breakdown of Value Revenues for qPCR and dPCR for the Years 2014, 2023 & 2030
  • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 237: Rest of Latin America Historic Review for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 238: Rest of Latin America 16-Year Perspective for qPCR and dPCR Instrumentation by Component - Percentage Breakdown of Value Revenues for Reagents & Consumables, Instruments and Software & Services for the Years 2014, 2023 & 2030
  • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 240: Rest of Latin America Historic Review for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 241: Rest of Latin America 16-Year Perspective for qPCR and dPCR Instrumentation by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories for the Years 2014, 2023 & 2030
• MIDDLE EAST
  • qPCR and dPCR Instrumentation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2023 (E)
  • TABLE 242: Middle East Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 243: Middle East Historic Review for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 244: Middle East 16-Year Perspective for qPCR and dPCR Instrumentation by Classification - Percentage Breakdown of Value Revenues for qPCR and dPCR for the Years 2014, 2023 & 2030
  • TABLE 245: Middle East Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 246: Middle East Historic Review for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 247: Middle East 16-Year Perspective for qPCR and dPCR Instrumentation by Component - Percentage Breakdown of Value Revenues for Reagents & Consumables, Instruments and Software & Services for the Years 2014, 2023 & 2030
  • TABLE 248: Middle East Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 249: Middle East Historic Review for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 250: Middle East 16-Year Perspective for qPCR and dPCR Instrumentation by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories for the Years 2014, 2023 & 2030
  • TABLE 251: Middle East Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2022 through 2030 and % CAGR
  • TABLE 252: Middle East Historic Review for qPCR and dPCR Instrumentation by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 253: Middle East 16-Year Perspective for qPCR and dPCR Instrumentation by Geographic Region - Percentage Breakdown of Value Revenues for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2023 & 2030
• IRAN
  • TABLE 254: Iran Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 255: Iran Historic Review for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 256: Iran 16-Year Perspective for qPCR and dPCR Instrumentation by Classification - Percentage Breakdown of Value Revenues for qPCR and dPCR for the Years 2014, 2023 & 2030
  • TABLE 257: Iran Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 258: Iran Historic Review for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 259: Iran 16-Year Perspective for qPCR and dPCR Instrumentation by Component - Percentage Breakdown of Value Revenues for Reagents & Consumables, Instruments and Software & Services for the Years 2014, 2023 & 2030
  • TABLE 260: Iran Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 261: Iran Historic Review for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 262: Iran 16-Year Perspective for qPCR and dPCR Instrumentation by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories for the Years 2014, 2023 & 2030
• ISRAEL
  • TABLE 263: Israel Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 264: Israel Historic Review for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 265: Israel 16-Year Perspective for qPCR and dPCR Instrumentation by Classification - Percentage Breakdown of Value Revenues for qPCR and dPCR for the Years 2014, 2023 & 2030
  • TABLE 266: Israel Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 267: Israel Historic Review for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 268: Israel 16-Year Perspective for qPCR and dPCR Instrumentation by Component - Percentage Breakdown of Value Revenues for Reagents & Consumables, Instruments and Software & Services for the Years 2014, 2023 & 2030
  • TABLE 269: Israel Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 270: Israel Historic Review for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 271: Israel 16-Year Perspective for qPCR and dPCR Instrumentation by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories for the Years 2014, 2023 & 2030
• SAUDI ARABIA
  • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 273: Saudi Arabia Historic Review for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 274: Saudi Arabia 16-Year Perspective for qPCR and dPCR Instrumentation by Classification - Percentage Breakdown of Value Revenues for qPCR and dPCR for the Years 2014, 2023 & 2030
  • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 276: Saudi Arabia Historic Review for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 277: Saudi Arabia 16-Year Perspective for qPCR and dPCR Instrumentation by Component - Percentage Breakdown of Value Revenues for Reagents & Consumables, Instruments and Software & Services for the Years 2014, 2023 & 2030
  • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 279: Saudi Arabia Historic Review for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 280: Saudi Arabia 16-Year Perspective for qPCR and dPCR Instrumentation by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories for the Years 2014, 2023 & 2030
• UNITED ARAB EMIRATES
  • TABLE 281: UAE Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 282: UAE Historic Review for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 283: UAE 16-Year Perspective for qPCR and dPCR Instrumentation by Classification - Percentage Breakdown of Value Revenues for qPCR and dPCR for the Years 2014, 2023 & 2030
  • TABLE 284: UAE Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 285: UAE Historic Review for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 286: UAE 16-Year Perspective for qPCR and dPCR Instrumentation by Component - Percentage Breakdown of Value Revenues for Reagents & Consumables, Instruments and Software & Services for the Years 2014, 2023 & 2030
  • TABLE 287: UAE Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 288: UAE Historic Review for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 289: UAE 16-Year Perspective for qPCR and dPCR Instrumentation by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories for the Years 2014, 2023 & 2030
• REST OF MIDDLE EAST
  • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 291: Rest of Middle East Historic Review for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 292: Rest of Middle East 16-Year Perspective for qPCR and dPCR Instrumentation by Classification - Percentage Breakdown of Value Revenues for qPCR and dPCR for the Years 2014, 2023 & 2030
  • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 294: Rest of Middle East Historic Review for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 295: Rest of Middle East 16-Year Perspective for qPCR and dPCR Instrumentation by Component - Percentage Breakdown of Value Revenues for Reagents & Consumables, Instruments and Software & Services for the Years 2014, 2023 & 2030
  • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 297: Rest of Middle East Historic Review for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 298: Rest of Middle East 16-Year Perspective for qPCR and dPCR Instrumentation by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories for the Years 2014, 2023 & 2030
• AFRICA
  • qPCR and dPCR Instrumentation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2023 (E)
  • TABLE 299: Africa Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 300: Africa Historic Review for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 301: Africa 16-Year Perspective for qPCR and dPCR Instrumentation by Classification - Percentage Breakdown of Value Revenues for qPCR and dPCR for the Years 2014, 2023 & 2030
  • TABLE 302: Africa Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 303: Africa Historic Review for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR<